7
After warming to room temperature, the solution was poured into
water (10 mL) and extracted with EA (10 mL × 3). The
combined extracts were washed with brine (15 mL) and dried
over Na2SO4 and concentrated in vacuo to afford crude β-nitro
sulfide. Finally, subjecting the mixture directly to purification on
silica gel chromatography (PE/EA) afforded the desired product
2.
m, 1H), 1.68 (ddq, J = 3.6, 14.0, 7.2 Hz, 1H), 1.89–1.71 (m,
ACCEPTED MANUSCRIPT
2H), 1.12 (t, J = 7.2 Hz, 3H), 0.96 (t, J = 7.2 Hz, 3H). 13C NMR
(101 MHz, CDCl3) δ: 133.2, 132.8, 129.2, 127.9, 92.5, 53.7,
22.9, 22.8, 11.5, 10.8.
4.3.6 4-Isopropylthio-3-nitrohexane (2f)
Colorless oil, 135mg, 66%, Rf = 0.46 (PE:EA = 40:1, v/v),
mixture of anti- and syn-2f. Anti-2f: 1H NMR (400 MHz, CDCl3)
δ: 4.37 (ddd, J = 2.8, 9.2, 10.8 Hz, 1H), 2.94 (ddd, J = 3.4, 9.2,
8.8 Hz, 1H), 2.93 (hept, J = 6.8 Hz, 1H), 2.25 (ddq, J = 14.8, 2.8,
7.3 Hz, 1H), 2.06 (ddq, J = 14.8, 10.8, 7.3 Hz 1H), 1.66 (ddq, J =
14.4, 3.4, 7.2 Hz, 1H), 1.47 (ddq, J = 14.4, 8.8, 7.2 Hz,1H), 1.30
(d, J = 6.8 Hz, 3H), 1.26 (d, J = 6.8 Hz, 3H), 1.06 (t, J = 7.3Hz,
3H), 0.97 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ:
4.3.1 2-Nitro-3-phenylthiobutane (2a) 9,10
Colorless oil, 163 mg, 77%, Rf = 0.47 (PE:EA = 20:1, v/v) ,
mixture of anti- and syn-2a. Anti-2a: 1H NMR (400 MHz,
CDCl3) δ: 7.48–7.45 (m, 2H), 7.37–7.31 (m, 3H), 4.50 (dq, J =
7.6, 6.7 Hz, 1H), 3.52 (dq, J = 7.6, 6.9 Hz, 1H), 1.68 (d, J = 6.7
1
Hz, 3H), 1.34 (d, J = 6.9 Hz, 3H). Syn-2a: H NMR (400 MHz,
1
94.2, 49.3, 36.3, 25.9, 24.8, 24.0, 23.5, 10.7, 10.6. Syn-2f: H
CDCl3) δ: 7.48–7.45 (m, 2H), 7.37–7.31 (m, 3H), 4.55 (dq, J =
5.7, 6.7 Hz), 3.82 (dq, J = 5.7, 7.0 Hz, 1H), 1.57 (d, J = 6.7 Hz,
3H), 1.29 (d, J = 7.0 Hz, 3H).
NMR (400 MHz, CDCl3) δ: 4.47 (ddd, J = 10.2, 6.6, 3.3 Hz, 1H),
2.98 (ddd, J = 9.7, 6.6, 3.6 Hz, 1H), 2.96–2.87 (m, 1H), 2.03–
1.98 (m, 1H), 1.91 (ddq, J = 14.8, 3.2, 7.2 Hz, 1H), 1.77 (ddq, J =
14.4, 3.6, 7.2 Hz, 1H), 1.52–1.40 (m, 1H), 1.30 (d, J = 6.8 Hz,
3H), 1.25 (d, J = 6.8 Hz, 3H), 1.04 (t, J = 7.2 Hz, 3H), 1.01 (t, J =
7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ: 94.1, 49.0, 36.3,
24.1, 23.8, 23.4, 23.0, 11.0, 10.8. IR (CH2Cl2) v (cm-1): 2970,
1550, 1398, 1368. HRMS (ESI) calcd. for fragment C9H19S+
[M+H-47u]+ or [M+H-HONO]+ m/z: 159.1202, found 159.1200.
4.3.2 2-Nitro-3-phenyl-3-phenylthiopropane (2b) 9,10
Yellowish oil, 211 mg, 77%, Rf = 0.48, 0.50 (PE:EA = 20:1, v/v),
mixture of anti- and syn-2b. Anti-2b: 1H NMR (400 MHz,
CDCl3) δ: 7.29–7.10 (m, 8H), 7.19–7.08 (m, 2H), 4.95 (dq, J =
9.39, 6.6 Hz, 1H), 4.56 (d, J = 9.39 Hz, 1H), 1.82 (d, J = 6.6 Hz,
3H). 13C NMR (101 MHz, CDCl3) δ: 136.5, 133.7, 132.4, 129.0,
1
126.6, 128.4, 128.2, 128.1, 86.9, 57.3, 18.1. Syn-2b: H NMR
4.3.7 4-tert-Butylthio-3-nitrohexane (2g)
(400 MHz, CDCl3) δ: 7.29–7.10 (m, 8H), 7.19–7.08 (m, 2H),
4.95 (dq, J = 9.38, 6.7 Hz, 1H), 4.57 (d, J = 9.38 Hz, 1H), 1.41
(d, J = 6.7 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ: 136.5, 134.0,
132.1, 129.0, 128.7, 128.5, 128.3, 127.9, 86.3, 56.7, 17.5.
Colorless oil, 118mg, 54%, Rf = 0.35 (PE:EA = 40:1, v/v),
mixture of anti- and syn-2g. 1H NMR (400 MHz, CDCl3) δ: 4.36
(ddd, J = 11.3, 8.8, 2.9 Hz, 1H), 2.99 (ddd, J = 8.8, 7.2, 4.4 Hz,
1H), 2.26 (ddq, J = 14.8, 2.9, 7.3 Hz, 1H), 1.98 (ddq, J = 14.8,
11.3, 7.3 Hz, 1H), 1.72 (ddq, J = 14.7, 4.4, 7.2 Hz, 1H), 1.58
(ddq, J = 14.7, 7.2, 7.2 Hz, 1H), 1.33 (s, 9H), 1.04 (t, J = 7.3 Hz,
3H), 0.96 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ:
93.6, 46.7, 44.1, 31.5, 27.4, 25.0, 10.8, 10.2. 1H NMR (400 MHz,
CDCl3) δ: 4.52 (ddd, J = 10.6, 5.2, 3.0 Hz, 1H), 3.03–2.97 (m,
1H), 2.50 (ddq, J = 14.8, 10.6, 7.2 Hz, 1H), 1.89 (ddq, J = 14.8,
3.0, 7.2 Hz, 1H), 1.79 (ddq, J = 14.4, 3.6, 7.2 Hz, 1H), 1.65–1.54
(m, 1H), 1.36 (s, 9H), 1.04 (t, J = 7.2 Hz, 3H), 0.98 (t, J = 7.2 Hz,
3H). 13C NMR (101 MHz, CDCl3) δ: 94.8, 47.5, 44.1, 31.2, 23.9,
21.4, 11.3, 11.2. IR (CH2Cl2) v (cm-1): 2970, 1551, 1400, 1366.
HRMS (ESI) calcd. for fragment C10H21S+ [M+H-47u]+ or
[M+H-HONO]+ m/z: 173.1358, found 173.1352.
4.3.3 3-Isopropylthio-2-nitrobutane (2c) 9
Colorless oil, 48 mg, 27%, Rf = 0.28 (PE:diethyl ether = 40:1,
1
v/v), mixture of anti- and syn-2c. Anti-2c: H NMR (400 MHz,
CDCl3) δ: 4.50 (dq, J = 7.0, 6.7 Hz, 1H), 3.29 (dq, J = 7.0, 6.9
Hz, 1H), 2.987 (hept, J = 6.7 Hz, 1H), 1.64 (d, J = 6.7 Hz, 3H),
1.35 (d, J = 6.7 Hz, 3H), 1.30 (d, J = 7.0 Hz, 3H), 1.25 (d, J = 6.9
Hz, 3H). 13C NMR (101 MHz, CDCl3) δ: 87.6, 42.5, 35.5, 23.8,
23.5, 20.1, 16.3. Syn-2c: 1H NMR (400 MHz, CDCl3) δ: 4.63 (dq,
J = 5.8, 6.7 Hz, 1H), 3.42 (dq, J = 5.8, 7.0 Hz, 1H), 2.994 (hept, J
= 6.7 Hz 1H), 1.57 (d, J = 6.7 Hz, 3H), 1.32 (d, J = 6.7 Hz, 3H),
1.27 (d, J = 7.0 Hz, 3H), 1.26 (d, J = 6.7 Hz, 3H). 13C NMR (101
MHz, CDCl3) δ: 86.7, 41.4, 35.4, 23.6, 23.3, 16.7, 13.9.
4.3.8 3-Nitro-4-phenylthiononane (2h) 9
4.3.4 3-tert-Butylthio-2-nitrobutane (2d)9
Yellowish oil, 117 mg, 41%, Rf = 0.56, 0.58 (PE:EA = 40:1, v/v),
mixture of anti- and syn-2h. Anti-2h: 1H NMR (400 MHz,
CDCl3) δ: 7.44–7.42 (m, 2H), 7.32–7.31 (m, 3H), 4.37 (ddd, J =
3.2, 9.2, 10.8 Hz, 1H), 3.31 (ddd, J = 3.6, 7.2, 9.2 Hz, 1H), 2.24
(ddq, J = 3.2, 14.8, 7.2 Hz, 1H), 1.98 (ddq, J = 10.8, 14.4, 7.2 Hz,
1H), 1.77–1.68 (m, 1H), 1.60–1.57 ( m, 1H), 1.53–1.44 (m, 2H),
1.34–1.25 (m, 4H), 0.93 (t, J = 7.2 Hz, 3H), 0.89 (t, J = 7.2 Hz,
3H). 13C NMR (101 MHz, CDCl3) δ: 133.3, 133.1, 129.2, 128.4,
Colorless oil, 24 mg, 12%, Rf = 0.36 (PE:diethyl ether = 40:1,
v/v), mixture of anti- and syn-2d. Anti-2d: H NMR (400 MHz,
1
CDCl3) δ: 4.45 (dq, J = 7.2, 7.2 Hz, 1H), 3.21 (dq, J = 7.2, 6.8
Hz, 1H), 1.63 (d, J = 6.8 Hz, 3H), 1.33 (s, 9H), 1.40 (d, J = 7.2
Hz, 3H). 13C NMR (101 MHz, CDCl3) δ: 87.9, 44.0, 40.9, 31.2,
1
22.5, 16.4. Syn-2d: H NMR (400 MHz, CDCl3) δ: 4.66 (dq, J =
5.2, 6.7 Hz, 1H), 3.40 (dq, J = 5.2, 7.1 Hz, 1H), 1.54 (d, J = 6.7
Hz, 3H), 1.36 (s, 9H), 1.28 (d, J = 7.1 Hz, 3H) 13C NMR (101
MHz, CDCl3) δ: 87.5, 44.3, 39.9, 31.0, 18.2, 13.4.
1
93.6, 52.2, 31.3, 31.2, 26.3, 25.2, 22.4, 13.9, 10.5. Syn-2h: H
NMR (400 MHz, CDCl3) δ: 7.46–7.42 (m, 2H), 7.35–7.27 (m,
3H), 4.43 (ddd, J = 4.0, 6.8, 10.0 Hz, 1H), 3.46 (ddd, J = 3.2, 6.8,
10.4 Hz, 1H), 2.12–1.80 (m, 2H), 1.77–1.68 (m, 1H), 1.60−1.57
(m, 1H), 1.53–1.44 (m, 2H), 1.34–1.25 (m, 4H), 0.95 (t, J = 7.2
Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ:
133.1, 132.8, 128.9, 127.9, 92.6, 51.9, 31.3, 29.5, 26.4, 25.2,
22.6, 13.8, 10.8.
4.3.5 3-Nitro-4-phenylthiohexane (2e) 9
Colorless oil, 121mg, 50%, Rf = 0.40 (PE:EA = 40:1, v/v),
mixture of anti- and syn-2e. Anti-2e: 1H NMR (400 MHz, CDCl3)
δ: 7.45–7.42 (m, 2H), 7.35–7.29 (m, 3H), 4.39 (ddd, J = 3.2, 9.2,
10.8 Hz, 1H), 3.28 (ddd, J = 3.6, 9.2, 9.2 Hz, 1H), 2.27 (ddq, J =
3.2, 14.4, 7.2 Hz, 1H), 1.99 (ddq, J = 10.8, 14.4, 7.2 Hz, 1H),
1.68 (ddq, J = 3.6, 14.6, 7.2 Hz, 1H), 1.49 (ddq, J = 9.2, 14.6, 7.2
Hz, 1H), 1.15 (t, J = 7.2 Hz, 3H), 0.93 (t, J = 7.2 Hz, 3H). 13C
NMR (101 MHz, CDCl3) δ: 133.2, 133.0, 129.2, 128.0, 93.7,
53.8, 25.2, 24.5, 11.2, 10.4. Syn-2e: 1H NMR (400 MHz, CDCl3)
δ: 7.45–7.42 (m, 2H), 7.35–7.29 (m, 3H), 4.45 (ddd, J = 4.0, 7.2,
10.8 Hz, 1H), 3.39 (ddd, J = 3.6, 7.2, 10.0 Hz, 1H), 2.13–2.02 (
4.3.9 4-Methyl-2-nitro-3-phenylthiopentane (2i) 9,10
Colorless oil, 90 mg, 37%, Rf = 0.23, 0.28, mixture of anti- and
1
syn-2i. Anti-2i: H NMR (400 MHz, CDCl3) δ: 7.45–7.42 (m,
2H), 7.36–7.27 (m, 2H), 7.27–7.20 (m, 1H), 4.80 (dq, J = 9.6, 6.8
Hz, 1H), 3.46 (dd, J = 4.4, 9.6 Hz, 1H), 1.91 (dhept, J = 4.4, 6.8